Literature DB >> 28521680

Fatty Acids and Effects on In Vitro and In Vivo Models of Liver Steatosis.

Laura Vergani1.   

Abstract

BACKGROUND: Fatty liver, or steatosis, is a condition of excess accumulation of lipids, mainly under form of triglycerides (TG), in the liver, and it is the hallmark of non-alcoholic fatty liver disease (NAFLD). NAFLD is the most common liver disorder world-wide and it has frequently been associated with obesity, hyperlipidemia and insulin resistance. Free fatty acids (FA) are the major mediators of hepatic steatosis; patients with NAFLD have elevated levels of circulating FA that correlate with disease severity.
METHODS: Steatosis is a reversible condition that can be resolved with changed behaviors, or that can progress towards more severe liver damages such as steatohepatitis (NASH), fibrosis and cirrhosis. In NAFLD, FA of exogenous or endogenous origin accumulate in the hepatocytes and trigger liver damages. Excess TG are stored in cytosolic lipid droplets (LDs) that are dynamic organelles acting as hubs for lipid metabolism.
RESULTS: In the first part of this review, we briefly reassumed the main classes of FA and their chemical classification as a function of the presence and number of double bonds, their metabolic pathways and effects on human health. Then, we summarized the main genetic and diet-induced animal models of NAFLD, as well as the cellular models of NAFLD.
CONCLUSIONS: In recent years, both the diet-induced animal models of NAFLD as well as the cellular models of NAFLD have found ever more application to investigate the mechanisms involved in NAFLD, and we referred to their advantages and disadvantages. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Fatty acids; Lipid Droplets (LDs); Nonalcoholic Fatty Liver Disease (NAFLD); Reactive Oxygen Specieszzm321990(ROS); fatty acid oxidation; hepatic steatosis; lipid metabolism; oxidative stress.

Mesh:

Substances:

Year:  2019        PMID: 28521680     DOI: 10.2174/0929867324666170518101334

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  5 in total

1.  Baicalein Prevents Fructose-Induced Hepatic Steatosis in Rats: In the Regulation of Fatty Acid De Novo Synthesis, Fatty Acid Elongation and Fatty Acid Oxidation.

Authors:  Pan Li; Ruoyu Zhang; Meng Wang; Yuwei Chen; Zhiwei Chen; Xiumei Ke; Ling Zuo; Jianwei Wang
Journal:  Front Pharmacol       Date:  2022-06-30       Impact factor: 5.988

2.  A Novel Identified Peptide Hormone "Metabolitin" Attenuates Lipid Absorption in the Small Intestine of Diabetic Mice with Nonalcoholic Fatty Liver Disease by Regulating Neurotensin and AMPK Signaling Pathway.

Authors:  Peng Xu; Shanjuan Wang; Dongyue Pang
Journal:  Evid Based Complement Alternat Med       Date:  2021-09-28       Impact factor: 2.629

3.  Aquaporin 9 Represents a Novel Target of Chronic Liver Injury That May Antagonize Its Progression by Reducing Lipotoxicity.

Authors:  Quancheng Cheng; Huiru Ding; Jinyu Fang; Xuan Fang; Huaicun Liu; Jianwei Wang; Chunhua Chen; Weiguang Zhang
Journal:  Oxid Med Cell Longev       Date:  2021-10-06       Impact factor: 6.543

4.  Dietary linoleic acid and the ratio of unsaturated to saturated fatty acids are inversely associated with significant liver fibrosis risk: A nationwide survey.

Authors:  Tingting Zhu; Xiao-Ting Lu; Zhao-Yan Liu; Hui-Lian Zhu
Journal:  Front Nutr       Date:  2022-07-26

5.  Natural Phenylethanoid Supplementation Alleviates Metabolic Syndrome in Female Mice Induced by High-Fructose Diet.

Authors:  Xiujun Zhan; Mingshuai He; Jierong Pei; Wenjing Fan; Charity Ngina Mwangi; Peng Zhang; Xin Chai; Miaomiao Jiang
Journal:  Front Pharmacol       Date:  2022-07-19       Impact factor: 5.988

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.